Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Showing 20 of 0 results

Not applicableStudy completedNCT00947232
What this trial is testing

Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI

Who this might be right for
Multiple SclerosisSpinal Cord Injury
University of Washington 123
Large-scale testing (Phase 3)Study completedNCT00648908
What this trial is testing

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 269
Not applicableStudy completedNCT03954717
What this trial is testing

Pilot Study Evaluating Functional and Wellness Outcomes of the Shepherd CAN DO MS Program

Who this might be right for
Multiple Sclerosis
Shepherd Center, Atlanta GA 111
Large-scale testing (Phase 3)Ended earlyNCT03283397
What this trial is testing

A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bosnalijek D.D 301
Testing effectiveness (Phase 2)Study completedNCT01403376
What this trial is testing

Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide

Who this might be right for
Multiple Sclerosis
Sanofi 128
Not applicableWithdrawnNCT03034317
What this trial is testing

NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Synapse Biomedical
Not applicableUnknownNCT01111435
What this trial is testing

A Prospective Study of Spasticity in Individuals With Multiple Sclerosis

Who this might be right for
Spasticity
Fraser, Cira, Ph.D., RN, ACNS-BC 110
Not applicableUnknownNCT02580435
What this trial is testing

Deciphering the Role of the Gut Microbiota in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sheba Medical Center 520
Large-scale testing (Phase 3)Study completedNCT04510220
What this trial is testing

9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Brigham and Women's Hospital 10
Not applicableUnknownNCT03703180
What this trial is testing

Vision Assessment With the Quick Contrast Sensitivity Function (qCSF) Method in Healthy Controls and MS

Who this might be right for
Multiple Sclerosis
Universitätsklinikum Hamburg-Eppendorf 200
Testing effectiveness (Phase 2)Study completedNCT05116540
What this trial is testing

Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hope Biosciences Research Foundation 24
Large-scale testing (Phase 3)Active Not RecruitingNCT06847724
What this trial is testing

Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Sandoz 183
Not applicableStudy completedNCT06760624
What this trial is testing

Effectiveness of Ofatumumab in Real-world Practice

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 779
Not applicableLooking for participantsNCT07289724
What this trial is testing

How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.

Who this might be right for
Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 57
Large-scale testing (Phase 3)Active Not RecruitingNCT04695080
What this trial is testing

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

Who this might be right for
Advanced Multiple SclerosisProgressive Multiple Sclerosis
Queen Mary University of London 204
Not applicableStudy completedNCT02440126
What this trial is testing

Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk

Who this might be right for
Multiple Sclerosis
Rocky Mountain MS Research Group, LLC 196
Very early researchLooking for participantsNCT07303790
What this trial is testing

This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Daishi Tian 9
Early research (Phase 1)Study completedNCT01884935
What this trial is testing

PK and PD Study of Natalizumab in Pediatric Subjects With RRMS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 13
Not applicableStudy completedNCT06232850
What this trial is testing

Wrist Position Sense in Individuals With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Pamukkale University 48
Not applicableStudy completedNCT04548310
What this trial is testing

Muscle Fatigue in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Gazi University 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation